Already have an account? Sign In
Colossal, founded in 2021 and headquartered in Austin, Texas, is a pioneering biotechnology company specializing in bioscience and genetic engineering. The company's primary focus is on genomics and species de-extinction, leveraging CRISPR technology to resurrect extinct species, starting with the woolly mammoth, and to protect critically endangered species and ecosystems.
Since its inception, Colossal has made significant strides in the field of genetic engineering and conservation. The company has successfully raised $237.6 million across multiple funding rounds, with its most recent Series B-II round in July 2024 securing $12.6 million. Colossal's valuation has seen impressive growth, reaching $1.19 billion in 2023, according to their Series B funding announcement.
As of now, there is no official information or confirmed reports regarding Colossal's IPO prospects. The company continues to focus on its groundbreaking research and development in de-extinction and genetic technologies. Investors interested in Colossal should keep an eye on the company's progress and any future announcements regarding potential public offerings.
Factors that may influence Colossal's decision to go public in the future could include its continued scientific advancements, market conditions in the biotechnology sector, and the company's financial performance. However, it's important to note that any discussion of a potential IPO at this stage would be purely speculative.
Already have an account? Sign In
While Colossal's IPO prospects remain uncertain, investors eager to explore opportunities in the de-extinction and genetic engineering space don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides the opportunity to invest in potential industry leaders like Colossal, with lower minimum investments than traditional private equity opportunities, allowing you to potentially benefit from their groundbreaking innovations and growth.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.